4//SEC Filing
Martin G. Kelly 4
Accession 0001209191-22-012309
CIK 0001428522other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 5:08 PM ET
Size
6.2 KB
Accession
0001209191-22-012309
Insider Transaction Report
Form 4
Martin G. Kelly
DirectorCEO and President
Transactions
- Award
Common Stock
2022-02-21+960,000→ 960,000 total
Footnotes (2)
- [F1]Represents restricted stock units awarded under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock (Common Stock). 240,000 of the restricted stock units will become earned in the event that during the period beginning on February 21, 2022 and ending on February 21, 2025 (Performance Period) the 30-day trading day average price of the Common Stock is equal to at least $10 per share, 240,000 of the restricted stock units will become earned if during the Performance Period, the 30-day trading day average price of the Common Stock is equal to at least $15 per share, and 480,000 of the restricted stock units will become earned if during the Performance Period, the 30-day trading day average price of the Common Stock is equal to at least $20 per share.
- [F2]A portion of such restricted stock units will vest upon the Common Stock price hurdle being met and a portion of such restricted stock units will vest at the end of the Performance Period, generally subject to continued service with RDUS through such dates and subject, in the case of those restricted stock units that vest at the end of the Performance Period, to a minimum 30-day trading day average price of the Common Stock as of the end of the Performance Period of $10 per share.
Documents
Issuer
Radius Health, Inc.
CIK 0001428522
Entity typeother
Related Parties
1- filerCIK 0001591756
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 5:08 PM ET
- Size
- 6.2 KB